Glycobiology Market Scope & Stakeholders - Global Forecast to 2021
Glycomics/Glycobiology Market by Product (Enzymes (Glycosyltransferase, Glycosidase), Instruments (HPLS, Mass Spectrometry, MALDITOF), Kits & Reagents (Glycoproteins)), Application (Diagnostic, Drug Discovery, Oncology), End User - Global Forecast to 2021
(firmenpresse) - The global glycomics/glycobiology market is expected to reach USD 1,211.4 Million by 2021 from USD 649.5 Million in 2016, at a CAGR of 13.3%. The market is segmented based on product, application, end user, and region.
On the basis of product, the market is segmented into enzymes, instruments, kits, and reagents. The enzyme segment is projected to grow at the highest CAGR during the forecast period. This growth is mainly attributed to their consumable nature and wide applications in a variety of R&D and drug discovery procedures.
On the basis of type, the glycomics instruments market is segmented into antibody arrays, HPLC, lectin arrays, MALDI-TOF, mass spectrometers, and other glycomics instruments. In 2016, the mass spectrometers segment is expected to account for the largest share of the glycomics instruments market. This growth can be attributed to the variety of applications and its importance in the glycomics R&D processes.
On the basis of end user, the market is segmented into academic research institutes, pharmaceutical & biotechnology companies, and contract research organizations. The academic research institutes segment is expected to account for the largest share of the market in 2016. This growth is attributed to rising availability of funding for life science research.
Geographically, the glycomics market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). Growth in the Asia segment is primarily driven by the increasing demand for the personalized medicine and commercialization of pharmaceutical and biotechnology research.
Get Free Brochure: https://www.marketsandmarkets.com/Market-Reports/glycobiology-market-132685525.html
Major players in the glycomics market are Agilent Technologies (U.S.), Bruker Corporation (U.S.), Danaher Corporation (U.S.), New England Biolabs (U.S.), ProZyme, Inc. (U.S.), Shimadzu Corporation (Japan), Merck KGaA (Germany), Takara Bio, Inc. (Japan), Thermo Fisher Scientific (U.S.), and Waters Corporation (U.S.).
Contact:
Mr. Shelly Singh
MarketsandMarkets
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
newsletter(at)marketsandmarkets.com
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
newsletter(at)marketsandmarkets.com
Datum: 31.08.2018 - 14:53 Uhr
Sprache: Deutsch
News-ID 1540434
Anzahl Zeichen: 2587
contact information:
Contact person:
Town:
Phone:
Kategorie:
Healthcare & Medical
Typ of Press Release: Erfolgsprojekt
type of sending: Veröffentlichung
Date of sending:
Anmerkungen:
Diese Pressemitteilung wurde bisher 398 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Glycobiology Market Scope & Stakeholders - Global Forecast to 2021
"
steht unter der journalistisch-redaktionellen Verantwortung von
marketsandmarkets (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
